Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo | Zendy

Casper de Boer | Zendy; Zachary Armstrong | Zendy; Vincent A. J. Lit | Zendy; Uri Barash | Zendy; Gijs Ruijgrok | Zendy; Ilanit Boyango | Zendy; Merle M. Weitzenberg | Zendy; Sybrin P. Schröder | Zendy; Alexi J. C. Sarris | Zendy; Nico J. Meeuwenoord | Zendy; Pedro Bule | Zendy; Yasmine Kayal | Zendy; Neta Ilan | Zendy; Jeroen D. C. Codée | Zendy; Israël Vlodavsky | Zendy; Herman S. Overkleeft | Zendy; G.J. Davies | Zendy; Liang Ping Wu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo

Author(s) -

Casper de Boer,

Zachary Armstrong,

Vincent A. J. Lit,

Uri Barash,

Gijs Ruijgrok,

Ilanit Boyango,

Merle M. Weitzenberg,

Sybrin P. Schröder,

Alexi J. C. Sarris,

Nico J. Meeuwenoord,

Pedro Bule,

Yasmine Kayal,

Neta Ilan,

Jeroen D. C. Codée,

Israël Vlodavsky,

Herman S. Overkleeft,

G.J. Davies,

Liang Ping Wu

Publication year - 2022

Publication title -

proceedings of the national academy of sciences

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 5.011

H-Index - 771

eISSN - 1091-6490

pISSN - 0027-8424

DOI - 10.1073/pnas.2203167119

Subject(s) - heparanase , extracellular matrix , metastasis , heparan sulfate , cancer cell , glycosaminoglycan , cancer , carcinogenesis , cancer research , microbiology and biotechnology , extracellular , chemistry , biology , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research